(478) TRV130, a novel biased opioid ligand, elicits increased analgesia with reduced adverse effects compared to morphine in healthy volunteers

Autor: Soergel, D., Subach, R., James, I., Violin, J., Skobieranda, F., Sadler, B., Burnham, N., Theisen, T., Lark, M., Webster, L.
Zdroj: In Journal of Pain April 2014 15(4) Supplement:S95-S95
Databáze: ScienceDirect